Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1731-1740 Newer>

Managed Care January 2005	Generic Prescription Fill Rates Vary Widely Across the Country Use of generic medications continues to increase, but the generic fill rate varies widely across the country, with possible explanations including variations in prescribing patterns, state regulations, etc.
Managed Care January 2005	Formulary Variability Challenges Physicians A recent study indicates that more than 60% of drugs were preferred on two to four of the six California formularies evaluated.
The Motley Fool January 31, 2005 Stephen D. Simpson	Wyeth's Waiting Game The end of diet-drug litigation may be in sight, but growth hasn't recovered yet. Anyone holding or looking to buy these shares needs to understand that it will take time to get growth back on track, and there could be setbacks along the way.
The Motley Fool January 31, 2005 Stephen D. Simpson	Merck Takes Another Body Blow Loss of exclusivity on major osteoporosis drug could take steam out of the recovery process. Investors in Merck just can't catch a break.
BusinessWeek February 7, 2005 Arlene Weintraub	A Remedy For Malpractice Malaise Hospitals are offering free coverage to recruit doctors from private practice
The Motley Fool January 28, 2005 Stephen D. Simpson	An Understated Scandinavian The Danish pharmaceutical may not be quite cheap enough to be a true value, but investors looking for a solid growth stock should see what's new with Novo Nordisk.
The Motley Fool January 28, 2005 Karl Thiel	Affymetrix Raking in the Chips The life sciences research chip maker is enjoying green pastures in the gene business. The company announced fourth-quarter revenues and profits that handily beat consensus expectations, and then gave an upbeat view of 2005.
The Motley Fool January 28, 2005 Brian Gorman	Baxter Plods On 2005 looks like another year of transition for Baxter International. The medical products and services concern reported that after currency adjustments, fourth-quarter 2004 revenue of $2.6 billion was essentially flat compared with the same period in 2003.
The Motley Fool January 28, 2005 Rich Duprey	Dentsply Dons a Smile Dental supply company rebounds in fourth quarter with record earnings and profits.
The Motley Fool January 28, 2005 Rich Duprey	Chiron: What Would Warren Do? Have the pharmaceutical company's vaccine woes made it a Buffett-worthy investment yet?
<Older 1731-1740 Newer> Return to current articles.